Skip to main content

Table 5 Seroprevalences of IgG+ and IgM+ antibodies to leptospirosis relative to clinical symptoms in the refugee population; * significant at 0.05

From: Prevalence of anti-Leptospira antibodies and associated risk factors in the Malaysian refugee communities

  IgG IgM
% (95% CL) P-value % (95% CL) P-value
Headache*
 Yes (n = 251) 0.8 (0.3–2.2) 0.001 22.7 (18.9–27.0) 0.552
 No (n = 182) 6.0 (2.8–12.0)   20.3 (13.6–28.8)  
Jaundice
 Yes (n = 39) 2.6 (0.2–13.6) 0.863 23.1 (12.1–38.9) 0.829
 No (n = 394) 3.0 (1.5–5.9)   21.6 (16.9–26.9)  
Myalgia
 Yes (n = 176) 2.3 (0.6–7.1) 0.454 21.6 (14.9–30.1) 0.961
 No (n = 257) 3.5 (2.1–5.8)   21.8 (18.0–26.1)  
Chills
 Yes (n = 125) 0.8 (0.1–3.7) 0.055 22.4 (16.5–29.5) 0.825
 No (n = 308) 3.9 (2.2–6.5)   21.4 (17.3–26.1)  
Fever*
 Yes (n = 235) 0.9 (0.3–2.3) 0.003 21.3 (17.6–25.4) 0.812
 No (n = 198) 5.6 (2.4–11.9)   22.2 (15.0–31.6)  
Diarrhea
 Yes (n = 82) 2.4 (0.4–10.0) 0.734 29.3 (19.1–41.8) 0.073
 No (n = 351) 3.1 (1.6–5.8)   19.9 (15.8–24.9)  
Abdominal discomfort
 Yes (n = 143) 3.5 (1.4–7.9) 0.676 25.9 (19.2–33.6) 0.144
 No (n = 290) 2.8 (1.5–5.0)   19.7 (15.8–24.1)  
  1. *Significance values from Log-Linear Models